Protein Report

Newswire Brief

← Back to Newswire

Cultured meat patents shift toward cost and scale as filings dip

ByEditor

Cultured meat patents shift toward cost and scale as filings dip

Patent filings for cultured meat fell 17% from a 2022 peak of 126 to 104 in 2024, according to the sixth edition of Appleyard Lees' Inside Green Innovation: Progress Report. Filings for plant-based meat analogues fell more steeply, by almost 40%, from 299 in 2021 to 187 in 2024. Both categories remain above their 2015–2019 levels. The intellectual property firm says investment and regulatory pressures appear to be changing what cultured meat developers patent, with more focus on production costs and scalability.

“The pressures on investment and regulation appear to be changing what companies protect rather than stopping them from filing.”

—James Myatt, partner, Appleyard Lees

  • Recent cultured meat filings target lower production costs, efficiency, and yields, as well as product flavor, texture, and nutritional quality. Activity includes cultured fats, hybrid cell-cultured and plant-based products, and 3D-printed meat.
  • South Korea led cultured meat filings for the first time in 2024 with 25, down from 29 the year before. US filings fell to 20, and Europe recorded its highest-ever total of 16.
  • Meatable of the Netherlands remains the leading cultured meat filer and was matched in the latest data by Zurich-based Mirai INT AG.
  • Europe narrowly kept its lead over the US in plant-based meat analogue filings, by 50 to 49, after a 40% drop from 2023.
  • Cargill has increased its plant-based meat analogue filings every year since 2020. It reached 16 in 2024, 10 more than the second-place filer.

Related Companies

This press release was distributed through Protein Report Newswire. For media inquiries, contact Appleyard Lees directly.

Cookie settings

We use cookies for core site functionality and optional features, such as embedded media. Choose whether to allow all cookies or keep strictly necessary only.